Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05950672 · ClinicalTrials.gov registry record · NA
Development and Evaluation CAT and Youth
A NA study, sponsored by Oregon State University.
- Completed
- Registry status
- NA
- Development phase
- 36
- Enrollment target
NCT05950672: Completed NA study, sponsored by Oregon State University.
NCT05950672 is a NA study that has completed, run by Oregon State University. The registered enrollment target is 36 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05950672, a NA study, has completed, sponsored by Oregon State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 36 participants
- Enrollment target
Study Summary
This R21 provides a multidisciplinary One Health approach to developing and evaluating a novel Cat Assisted Training (CAT) animal assisted intervention (AAI) for early adolescents with developmental disabilities (DD) and their family cat. Cat social behavior and welfare is heavily influenced by human behavior and training, making it highly likely that cats would also benefit from this program. There remains a critical need for further empirical evaluation of AAI practices, especially those that target the specific needs of youth with disabilities. Further extending the development and evaluation of activity-based AAIs beyond those that include dogs and horses also helps address the critical need to consider and include diverse human participants, creating new equitable opportunities for AAI involvement to those who may have access to cats, but not dogs and horses (due to practical, health, cultural, socio-economic, or other personal reasons).
Primary Outcome
Cats in the intervention group participated in a structured three-phase assessment: two minutes in the testing room with their child owner, two minutes alone, and then a reunion phase when the child returns. All sessions were video recorded. Two independent raters classified each cat's attachment style using a predefined behavioral ethogram, with primary emphasis on the cat's response during the reunion. Possible attachment classifications include Secure, Insecure-Ambivalent, Insecure-Avoidant,
Interventions
- BEHAVIORAL CAT Intervention Group
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2023-05-30 |
| Est. Completion | 2025-08-21 |
| Phase | NA |
What the finished NCT05950672 record still lists
NCT05950672 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 36 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 1 intervention - of which CAT Intervention Group is the first listed.
NCT05950672 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05950672 about?
NCT05950672 is a clinical study titled "Development and Evaluation CAT and Youth". This R21 provides a multidisciplinary One Health approach to developing and evaluating a novel Cat Assisted Training (CAT) animal assisted intervention (AAI) for early adolescents with developmental disabilities (DD) and their family cat. Cat social behavior and welfare is heavily influenced by huma...
What is the current status of trial NCT05950672?
This trial is currently completed. It is a NA study. The enrollment target is 36 participants. The study started on 2023-05-30. Estimated completion is 2025-08-21.
What interventions are being tested in trial NCT05950672?
The interventions under investigation include: CAT Intervention Group (BEHAVIORAL).
Who is sponsoring clinical trial NCT05950672?
This trial is sponsored by Oregon State University, which has 33 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05950672's enrollment target sits among peer trials
36 1541st of 2000 higher than 437 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00929006 · 36 participants · Early Phase 1
Acute Progesterone Suppression of Wake vs. Sleep Luteinizing Hormone Pulse Frequency in Pubertal Girls With and Without Hyperandrogenism
- NCT01891318 · 36 participants · Phase 1
Neoadjuvant Radiosurgery for Resectable Brain Metastases: Phase I/II Study
- NCT02291848 · 36 participants · Phase 1
Tumor-Associated Antigen-Specific Cytotoxic T-Lymphocytes for Multiple Myeloma
- NCT02366819 · 36 participants · Phase 4
Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI